Synonyms: compound 3g [PMID 18800763] | GSK 690693 | GSK-690693
Compound class:
Synthetic organic
Comment: GSK-690693 is an ATP competitive, pan-AKT kinase inhibitor [2-3].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
GSK-690693 inhibits other AGC family kinases due to their shared ATP domain structure (eg MSK1, ROCK1, and RSK, and to a lesser extent PKA, PrkX, and PKC isozymes) [2]. CAMK family kinases AMPK and DAPK3 and STE family kinases PAK4, 5, and 6 are also inhibited by GSK-690693 [2]. See Table 5 in Heerding et al (2008) [2] for IC50s for all kinases screened for GSK-690693 inhibition. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|